Thomason; Arlen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thomason; Arlen.The latest application filed is for "methods for treating obesity using fibroblast growth factor-like polypeptides".

Company Profile

0.12.11

Thomason; Arlen - Walterville OR
Thomason; Arlen - Thousand Oaks CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for treating obesity using fibroblast growth factor-like polypeptides Grant 8,053,408 - Thomason , et al. November 8, 2	2011-11-08
Methods for treating obesity using fibroblast growth factor-like polypeptides Grant 8,030,275 - Thomason , et al. October 4, 2	2011-10-04
Antibodies to fibroblast growth factor-like polypeptides Grant 7,887,799 - Thomason , et al. February 15, 2	2011-02-15
Antibodies to fibroblast growth factor-like polypeptides Grant 7,879,323 - Thomason , et al. February 1, 2	2011-02-01
Methods for treating obesity using fibroblast growth factor-Like polypeptides App 20100233169 - Thomason; Arlen ; et al.	2010-09-16
Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides App 20100226921 - Thomason; Arlen ; et al.	2010-09-09
Nucleic acid molecules encoding fibroblast growth factor-like polypeptides Grant 7,727,742 - Thomason , et al. June 1, 2	2010-06-01
Methods for treating diabetes using fibroblast growth factor-like polypeptides Grant 7,704,952 - Thomason , et al. April 27, 2	2010-04-27
Methods for treating diabetes using fibroblast growth factor-like polypeptides Grant 7,700,558 - Thomason , et al. April 20, 2	2010-04-20
Vectors and recombinant host cells comprising nucleic acid molecules encoding Fibroblast Growth Factor-like polypeptides Grant 7,695,938 - Thomason , et al. April 13, 2	2010-04-13
Fibroblast growth factor-like polypeptides Grant 7,696,172 - Thomason , et al. April 13, 2	2010-04-13
Fibroblast growth factor-like polypeptides and variants thereof Grant 7,671,180 - Thomason , et al. March 2, 2	2010-03-02
Fibroblast growth factor-like polypeptides and variants thereof Grant 7,667,008 - Thomason , et al. February 23, 2	2010-02-23
Fibroblast Growth Factor-Like Polypeptides App 20100028349 - Thomason; Arlen ; et al.	2010-02-04
Fibroblast Growth Factor-Like Polypeptides App 20090324599 - Thomason; Arlen ; et al.	2009-12-31
Fibroblast Growth Factor-Like Polypeptides App 20090148885 - Thomason; Arlen ; et al.	2009-06-11
Fibroblast Growth Factor-Like Polypeptides App 20090118182 - Thomason; Arlen ; et al.	2009-05-07
Fibroblast Growth Factor-Like Polypeptides App 20090018077 - Thomason; Arlen ; et al.	2009-01-15
Fibroblast Growth Factor-Like Polypeptides App 20090018076 - Thomason; Arlen ; et al.	2009-01-15
Fibroblast Growth Factor-Like Polypeptides App 20090017498 - Thomason; Arlen ; et al.	2009-01-15
Fibroblast growth factor-like polypeptides Grant 7,459,540 - Thomason , et al. December 2, 2	2008-12-02
Fibroblast Growth Factor-Like Polypeptides App 20080071066 - Thomason; Arlen ; et al.	2008-03-20
Fibroblast Growth Factor-Like Polypeptides App 20080071065 - Thomason; Arlen ; et al.	2008-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.